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Hydroxylated metabolites of polychlorinated biphenyls (OHPCBs) are inhibitors and substrates 
for various human sulfotransferases (SULTs). Although the rat is often used in toxicological 
studies on PCBs, the interactions of OHPCBs with rat SULTs are less well understood.  In the 
present study, 15 OHPCBs were investigated as potential substrates or inhibitors of purified 
recombinant rSULT1A1 and rSULT2A3, the major family 1 and family 2 SULTs present in rat 
liver, respectively. None of these OHPCBs were substrates for rSULT2A3, 11 weakly inhibited 
rSULT2A3-catalyzed sulfation of dehydroepiandrosterone, and four had no effect on the 
reaction. With rSULT1A1, 4-OH PCB 8, 4’-OH PCB 3, 9, 12, 35, and 6’-OH PCB 35 were 
substrates, while 4’-OH PCB 6, 4-OH PCB 14, 4’-OH PCB 25, 4’-OH PCB 33, 4-OH PCB 34, 
4-OH PCB36, 4’-OH PCB 36, 4’-OH PCB 68, and 4-OH PCB 78  inhibited the sulfation of 2-
naphthol catalyzed by this enzyme. OHPCBs with a 3,5-dichloro-4-hydroxy substitution were 
the most potent inhibitors of rSULT1A1, and the placement of chlorine atoms in the ortho- and 
meta- positions on either ring of para-OH PCBs resulted in significant differences in activity as 
substrates and inhibitors. The specificity of rSULT1A1 for several inhibitory OHPCBs was 
altered by pretreatment of the enzyme with oxidized glutathione (GSSG). Four OHPCBs that 
were inhibitors of rSULT1A1 under reducing conditions became substrates following 
pretreatment of the enzyme with GSSG.   This alteration in specificity of rSULT1A1 for certain 
OHPCBs suggests that conditions of oxidative stress may significantly alter the sulfation of some 








Although the manufacture of polychlorinated biphenyls (PCBs) has been legally banned 
in the US for over 30 years, they are persistent in the environment in large quantities and 
hazardous to public health  (ASTDR, 2000; Robertson and Hansen, 2001). The originally 
released PCBs were predominantly highly chlorinated (6 or more chlorines per molecule). 
However, PCBs in soils and marine sediments can be de-chlorinated to lower chlorinated 
congeners (Abramowicz, 1995; Master et al., 2002;). Lower chlorinated PCBs are semi-volatile 
and present in urban atmospheres of various areas in the U.S. and other countries (Wethington 
and Hornbuckle, 2005; Ruzickova et al., 2008), and they move in dynamic balance among the 
atmosphere, water, and soil.  
PCBs are biotransformed by cytochrome P450 (CYP) isoforms to hydroxylated PCBs 
(OHPCBs) (Kaminsky et al., 1981; Safe, 1994; McLean et al., 1996; Ludewig et al., 2007). 
Lower chlorinated PCBs are often more susceptible than highly chlorinated congeners to 
biotransformation in CYP- catalyzed reactions to OHPCBs.  PCBs administered to rats are 
initially deposited in the liver and muscles, and then translocated to the skin and adipose tissue 
(Matthews and Anderson, 1975). The OHPCBs, however, may be selectively concentrated in the 
liver as compared to adipose tissue, as indicated by a study where the concentration of OHPCBs 
was about 20 times higher in liver than that in adipose tissues, whereas the concentrations of 
total PCBs were not significantly different between the two tissues (Guvenius et al., 2002). After 
CYP-catalyzed hydroxylation of PCBs, the resulting OHPCBs can be conjugated in reactions 
catalyzed by enzymes such as sulfotransferases (Liu et al., 2006; Wang et al., 2006), UDP-
glucuronosyltransferases (Schnellmann et al., 1984; Tampal et al., 2002), and  glutathione S-




The sulfotransferases (SULTs) constitute a superfamily of biotransformation enzymes 
catalyzing the sulfation of a spectrum of substrates ranging from endogenous hormones and 
neurotransmitters to xenobiotics. OHPCBs have been observed to be inhibitors and substrates of 
human cytosolic sulfotransferases (hSULTs), e.g., hSULT1A1 (Wang et al., 2006), hSULT1E1 
(Kester et al., 2000), and hSULT2A1 (Liu et al., 2006), major family 1 and family 2 SULTs in 
humans. While hundreds of toxicological investigations on PCBs have been conducted utilizing 
rats or tissues/cells derived from rats, relatively little is known about the sulfation of OHPCBs in 
the rat. Moreover, the specificities of individual SULTs for OHPCBs in that species have not 
been extensively studied. This gap in our knowledge could potentially cause uncertainty in the 
extrapolation of studies from rat to human. We hypothesized that OHPCBs interact with 
rSULT1A1 (also previously known as aryl sulfotransferase IV) and rSULT2A3 (also previously 
known as sulfotransferase STa), two isoforms of SULT in the rat that are orthologous to human 
isoforms hSULT1A1 and hSULT2A1, respectively.  
rSULT1A1 is also of interest due to its ability to be regulated by the thiol:disulfide status 
of its environment (Marshall et al., 1997; Marshall et al., 2000; Duffel et al., 2001).  There are 
five cysteine residues, located at positions 66, 82, 232, 283, and 289 in each of the two identical 
subunits (homodimers) of rSULT1A1. It has been shown that the kinetics, specificity, and pH 
optima of rSULT1A1 are regulated by the oxidation status of Cys66 (i.e., conversion among the 
free thiol, a glutathione-protein mixed disulfide, and an intramolecular disulfide between Cys 66 
and Cys232) (Marshall et al., 1997; Marshall et al., 2000). These previous studies on rSULT1A1 
led to our second hypothesis that interactions of OHPCBs with the purified rSULT1A1 and 
rSULT2A3 would be modified by changing the oxidative environment of the enzyme with 




substrate of rSULT2A3, catalyzed by hepatic cytosol from male rats has been reported to be 
unaffected by treatment with oxidized glutathione (Maiti et al., 2004), the potential for substrate-
specific modulation of a homogeneous preparation of rSULT2A3 by oxidized glutathione has not 
been investigated.  
Thus, in the present study, 15 lower chlorinated congeners of OHPCBs, each bearing one 
hydroxyl (at the para- position for 14 and the ortho- position for 1 of the congeners) and 1-4 
chlorine atoms in different substitution patterns, were investigated for their interaction with 
homogeneous recombinant rSULT1A1 and rSULT2A3 as substrates and inhibitors. The potential 
for alteration of the specificity of rSULT1A1 and rSULT2A3 for OHPCBs was explored by 









Materials and Methods 
Chemicals. The synthesis and characterization of twelve OHPCBs (abbreviations and 
chemical structures shown in Table 1) has been reported previously (Lehmler and Robertson, 
2001). In addition, three new OHPCBs were synthesized by Suzuki coupling of the 
corresponding chlorinated benzeneboronic acids and a suitable bromo chloro anisole, followed 
by demethylation with boron tribromide.  
3,2’-Dichloro-biphenyl-4-ol (4’-OH PCB 6). White solid; mp=46-47°C (>99% by GC); 
1H NMR (400 MHz, CDCl3): δ/ppm 7.44-7.42 (m, 1H), 7.40 (d, J=2.1Hz, 1H), 7.28-7.23 (m, 
4H), 7.05 (d, J=8.4Hz, 1H), 5.62 (br s, 1H, -OH); 13C NMR (100MHz, CDCl3): δ/ppm 151.0, 
139.0, 132.9, 132.7, 131.4, 130.2, 130.1, 129.9, 128.9, 127.1, 119.7, 116.0; MS m/z (relative 
intensity): 238 (100, M-H), 139 (80).  
2,4’-Dichloro-biphenyl-4-ol (4-OH PCB 8). White solid; mp=107-108°C (>99% by GC); 
1H NMR (400 MHz, CDCl3): δ/ppm 7.41-7.34 (m, 4H), 7.19 (d, J=8.4Hz, 1H), 7.00 (d, J=2.6Hz, 
1H), 6.82 (dd, J=8.4, 2.6Hz, eH), 5.32 (br s, 1H, -OH); 13C NMR (100MHz, CDCl3): δ/ppm 
155.6, 137.6, 133.5, 133.1, 132.2, 132.1, 131.1, 128.4, 117.0, 114.5; MS m/z (relative intensity): 
238(100, M-H), 168(36), 139(45). 
2,3’,4’-Trichloro-biphenyl-4-ol (4-OH PCB 33). White solid; mp=103-104°C (>99% by 
GC); 1H NMR (400 MHz, CDCl3): δ/ppm 7.51-7.47 (m, 2H), 7.27-7.25 (m, 1H), 7.18 (d, 
J=8.4Hz, 1H), 6.99 (d, J=2.6Hz, 1H), 6.81 (dd, J=8.4, 2.6Hz, 1H), 5.03 (br s, 1H, -OH); 13C 
NMR (100MHz, CDCl3): δ/ppm 156.0, 139.1, 133.1, 132.3, 132.1, 131.7, 131.6, 131.0, 130.2, 
129.2, 117.2, 114.6; MS m/z (relative intensity): 272 (100, M-H), 202 (36), 173 (18), 139 (15).  
Adenosine 3’-phosphate 5’-phosphosulfate (PAPS) was obtained from Sigma-Aldrich 




than 98% as determined by HPLC. 2-Naphthol, dehydroepiandrosterone (DHEA), 1-octylamine, 
adenosine 3’,5’-diphosphate (PAP), PAP-agarose, reduced glutathione, and oxidized glutathione 
were used as obtained from Sigma-Aldrich (St. Louis, MO). Dithiothreitol (DTT) was from 
Research Products International Corp. (Mt. Prospect, IL). All other chemicals and reagents were 
of the highest purity commercially available. 
Expression and purification of recombinant Rat SULTs. Recombinant E. coli BL 21 
(DE3) cells that expressed either rSULT1A1 (Chen et al., 1992) or rSULT2A3 (Sheng and 
Duffel, 2001) were established using a pET-3c vector as previously described. Cells were grown, 
cell extract was prepared, and the enzymes were purified using minor modifications of a 
procedure developed for hSULT2A1 (Liu et al., 2006). Briefly, each E. coli cell culture was 
grown in 3 mL of Luria broth medium (supplemented with 50 μg/mL of ampicillin for cell 
selection) at 29 °C.  After 24 h, 100 μL aliquots of the cell suspension were transferred to each of 
four 20 mL portions of fresh culture medium (Luria broth medium with 50 μg/mL of ampicillin) 
and incubated at 29 °C for 24 h. Finally, each 20 mL culture was added to 400 mL of fresh 
culture medium and incubated with shaking (210 rpm) at 29 °C for 24 h. Isopropyl-1-thio-D-
galactopyranoside (1 mM) was present in the final stage of rSULT2A3-expressing cell cultures 
for 23 h (added 1 h after the start of final stage culture), but was not utilized for rSULT1A1-
expressing cell cultures. The cells (weighing about 14 g) were disrupted by sonification in 20 mL 
of buffer A (10 mM tris-HCL at pH 7.5, 0.25M sucrose, 10% (v/v) glycerol, 1 mM 
phenylmethylsulfonylfluoride, 1 μM pepstatin, 1 mM DTT, and 2mg/L antipain). The cell 
homogenate was centrifuged at 24,000 × g for 30 min, and the supernatant fraction was collected 
as cell extract. Each SULT isoform was purified using PAP-agarose affinity column 




the column, the column was washed with 200 mL buffer B (10 mM tris-HCL buffer at pH 7.5, 
0.25 M sucrose, 10 % (v/v) glycerol, 1 μM pepstatin, 1 mM DTT, 2 mg/L antipain, and 0.05% 
(v/v) Tween 20) to remove non-specifically bound proteins. rSULT1A1 was eluted with a linear 
gradient formed between 20 mL buffer B and 20 mL buffer B containing 100 μM PAP. The 
linear gradient for eluting rSULT2A3 was formed between 20 mL buffer B and 20 mL buffer B 
containing 50 μM PAP. Residual PAP was removed by gel filtration chromatography on a PD-10 
column (Amersham Biosciences, Piscataway, NJ) eluted with buffer B. The protein was 
concentrated by ultrafiltration with a 10-mL Amicon stirred cell and PM-10 membrane 
(Millipore Corp., Bedford, MA).   
Assay of OHPCBs as potential substrates. The sulfation reactions were carried out in a 
total volume of 30 μL, with 0.25 M potassium phosphate buffer at pH 7.0, 200 μM PAPS, 7.5 
mM 2-mercaptoethanol, and each OHPCB in varied concentrations ranging from 3 μM to either 
its limit of solubility or 400 μM, as appropriate. Acetone was used as co-solvent for each 
OHPCB and was present in each final reaction mixture at a concentration of 3.3% (v/v). Either 
rSULT1A1 (0.75 μg) or rSULT2A3 (0.5 μg) was added to initiate each reaction, which was 
carried out at 37 °C for 6 min and 15 min, respectively. Each reaction was terminated by the 
addition of 30 μL methanol. The rate of sulfation was determined by substrate-dependent 
formation of PAP as analyzed by HPLC (Duffel et al., 1989; Sheng et al., 2001).  
Inhibition of SULTs by OHPCBs. Those OH-PCBs that were not substrates were 
investigated for potential inhibition of the sulfation of 2-naphthol (for rSULT1A1) and DHEA 
(for rSULT2A3).  Reactions were conducted under non-saturating substrate concentrations (i.e., 
with 15 μM 2-naphthol or 10 μM DHEA). Each OHPCB was studied at various concentrations 




rSULT1A1 or 0.5 μg rSULT2A3 was used in each assay. Reactions were carried out at 37 °C for 
6 min, and the sulfation rate was determined by substrate-dependent formation of PAP as 
described above. 
Effect of oxidized glutathione on the specificities of SULTs for OHPCBs. For studies 
on the effect of disulfide on the SULTs, DTT was removed from the original enzyme 
preparations according to a previously reported method (Marshall et al., 1997), with minor 
modifications. Briefly, either rSULT1A1 or rSULT2A3 in buffer B (0.5-1 mL) was added to a 5 
ml PD-10 gel filtration column that had been equilibrated with buffer C (i.e., all components of 
buffer B except DTT). After elution with buffer C, the protein (3-5 mL) was concentrated to 0.5-
1.0 mL by ultrafiltration using a 10-mL Amicon stirred cell with a PM-10 membrane. All 
manipulations were carried out at 4 °C. The resulting concentration of DTT was less than 0.06 
mM as determined by a standard assay for thiols employing 5,5’-dithiobis(2-nitrobenzoic acid) 
(DTNB) (Jocelyn, 1987).  
Stock solutions of reduced and oxidized glutathione (10 mM) were prepared in buffer C, 
and the pH was adjusted with potassium hydroxide to 7.5. Each enzyme:glutathione mixture was 
prepared in a 9:1 ratio (v:v), such that the final concentration of either reduced or oxidized 
glutathione was 1 mM and there was a 10% decrease in protein concentration. Each enzyme in 
argon-saturated buffer C containing either 1 mM reduced glutathione (GSH) or 1 mM oxidized 
glutathione (GSSG) was incubated at 25°C for 1 h. Aliquots of these solutions of enzymes were 
then used in the assay of sulfation reactions as described above, but without addition of any 
additional reducing agents to the assay mixtures (i.e., 2-mercaptoethanol was absent from the 
reaction mixtures). Reaction mixtures contained 0.25 M potassium phosphate at pH 7.0, 200 μM 




than 100 μM, and an aliquot of each enzyme that had been pretreated with either 1 mM GSH or 1 
mM GSSG (0.75 μg rSULT1A1 or 0.5 μg rSULT2A3). The volume of the aliquot of enzyme 
(1.5-2.2 μL) added to each reaction mixture did not affect the pH of the assay. Three replicates 
were carried out for each treatment. Reaction mixtures were incubated at 37 °C for 6 min 
(rSULT1A1) and 15 min (rSULT2A3), respectively. An assay containing all components except 
OHPCB was utilized to determine the OHPCB-dependent formation of PAP with either the 
reduced or oxidized enzyme. These control experiments in the absence of any OHPCB exhibited 
less than 18 μM PAP (rSULT1A1) and 13 μM PAP (rSULT2A3) formed in the course of the 
assay period, and these controls were subtracted from the PAP formed in the presence of 
OHPCBs to determine the rate of substrate-dependent formation of PAP. For those OHPCBs that 
were observed to be substrates for oxidized rSULT1A1, multiple concentrations of OHPCBs 
were then utilized under the same conditions as described above. Two substrates for reduced 
rSULT1A1, 4’-OH PCB 9 and 6’-OH PCB 35 (representing kinetic profiles both with and 
without substrate inhibition, respectively) were also examined for differences in sulfation 
catalyzed by GSH- and GSSG-pretreated rSULT1A1. After each preincubation of enzyme with 
GSH at 25 °C for 1 h, an aliquot of the mixture was analyzed with DTNB (Jocelyn, 1987) for 
thiol content in order to determine the stability of the reduced glutathione under the experimental 
conditions.   
Reversibility of the effect of GSSG on SULT1A1 by reduction. After removal of 
reducing agents by PD-10 chromatography, rSULT1A1 was pretreated with either 5 mM DTT or 
1 mM GSSG at 25°C for 1 hr as described above. The resulting enzyme preparations were 
utilized to determine substrate-dependent formation of PAP with either 2-naphthol (250 μM) or 




with 5 mM DTT (incubation at 25°C for 1 h) to reduce  disulfide bonds in the enzyme, and the 
rate of sulfation of either 2-naphthol or 4’-OH PCB 6 was then determined.  
Solubility of OHPCBs in the SULT assays. The solubility of each OHPCB was 
determined at 37°C in 0.25 M potassium phosphate at pH 7.0 containing 3.3% (v/v) acetone and 
7.5 mM 2-mercaptoethanol.  The previously described use of light scattering at 400 nm 






Interaction of OHPCBs with rSULT1A1 and rSULT2A3 as substrates and 
inhibitors in the presence of reducing agents. Under commonly used SULT assay conditions 
in the presence of reducing agents (i.e., DTT during enzyme purification and 2-mercaptoethanol 
in reaction mixtures), six OHPCBs were observed to be substrates for rSULT1A1. As shown in 
Fig. 1A, four of these six OHPCBs demonstrated substantial substrate inhibition, while two, 4’-
OH PCB 35 and 6’-OH PCB 35, did not show substrate inhibition within their limits of 
solubility. The maximal sulfation rates, and the concentrations at which maximal sulfation rates 
were observed, varied among the individual OHPCBs. The concentration-velocity curves for the 
six OHPCBs were complex and not amenable to description by a simple enzyme kinetic model. 
Although six of the OHPCBs were substrates, the other nine OHPCBs were found to be 
inhibitors of rSULT1A1 when 2-naphthol was used as the substrate. Eight of these inhibitors 
displayed full (100%) inhibition of the enzyme (Fig. 1B), while 4’-OH PCB 36 (data not shown) 
reached only about 65% inhibition of the enzyme at its limit of solubility (i.e., 50 μM). As shown 
in Fig. 1B, large variations in the potency of individual OHPCBs in inhibiting rSULT1A1 were 
seen. The calculated IC50 values for each OHPCB are shown in Table 1, and these ranged from 
0.27 to 57.7 μM, with 4-OH PCB 14 as the most potent inhibitor. 
Unlike the case with rSULT1A1, none of the fifteen OHPCBs showed any ability to 
serve as a substrate for rSULT2A3. Moreover, none of the OHPCBs examined were potent 
inhibitors of the sulfation of DHEA catalyzed by rSULT2A3. Eleven OHPCBs demonstrated 
weak inhibition of rSULT2A3; eight of them (4’-OH PCB 3, 4’-OH PCB 9, 4’-OH PCB 12, 4-
OH PCB 14, 4-OH PCB 34, 4’-OH PCB 36, 4’-OH PCB 68, 4-OH PCB 8) had IC50 values 




less than 50% inhibition within their solubility limits. 4'-OH PCB 9 was the only one that 
attained full inhibition of the enzyme. The other four OHPCBs showed neither inhibitory nor 
substrate activity toward rSULT2A3 within their limits of solubility. 
Structure-activity analysis of OHPCBs with rSULT1A1. As shown in Fig. 2A-C, the 
most potent inhibitors of rSULT1A1 have a 3,5 dichloro-4-hydroxy substitution pattern.  For 
example, a 6-fold difference in IC50 is observed with the addition of a 5’-chlorine atom to 4’-OH 
PCB 25 (i.e., 4’-OH PCB 68). The presence or absence of a chlorine atom at the 4-position of the 
non-phenolic ring has a small effect on the magnitude of the IC50 value observed (Fig. 2A and 
2C).  However, a change in chlorine atoms between the 2 and 3 positions on the aromatic ring 
bearing a 4-OH group (Fig. 2D) results in large changes in the interactions with rSULT1A1, as is 
also the case when chlorine atoms at the 2’ and 3’ positions (on the non-phenolic ring) are 
altered in a 3-chloro-4-OH PCB (Fig. 2E).  Thus, there appears to be a significant role of 
chlorine atoms in the 2 (or 2’) and 3 (or 3’) positions of 4’-OH PCBs in determining their ability 
to serve as substrates and inhibitors of rSULT1A1. 
Effects of pretreatment of rSULT1A1 and rSULT2A3 with oxidized and reduced 
glutathione on their abilities to catalyze sulfation of OHPCBs. The nine OHPCBs that were 
not substrates for either SULT under the assay conditions used for experiments in Table 1, were 
further examined for their potential to serve as substrates following treatment of the enzymes 
with oxidized and reduced glutathione.   In order to examine the response of these enzymes to 
the thiol:disulfide ratio in their environment, the DTT present during purification was removed 
by gel filtration chromatography, and the enzymes were incubated for one hour at 25°C under 
argon in the presence of either 1 mM GSH or 1 mM GSSG as described in Materials and 




GSH was verified by reaction of an aliquot with DTNB. Following the incubation of rSULT1A1 
with either GSH or GSSG, the activity of the enzyme was determined as described in Materials 
and Methods.  A final concentration of 100 μM in each assay was utilized for 4’-OH PCB 6, 4-
OH PCB 14, 4’-OH PCB 25, and 4-OH PCB 34.  The other OHPCBs (i.e., 4’-OH PCB 33, 4-OH 
PCB 36, 4’-OH PCB 36, 4’-OH PCB 68, and 4-OH PCB 78) were examined at concentrations 
equal to the limits of their solubility shown in Table 1.  None of these nine OHPCBs were 
substrates for the rSULT1A1 that had been pretreated with 1 mM GSH, a result similar to that 
obtained under standard assay conditions where the enzyme was in a buffer containing DTT and 
2-mercaptoethanol was present in the reaction mixtures (as described above). However, with 
rSULT1A1 that had been pretreated with 1 mM GSSG, four of the OHPCBs became substrates 
for the enzyme with the following rates of sulfation (expressed in nmoles product/min/mg 
protein; n=3): 4’-OH PCB 6 (43.2 ± 9.6)  , 4-OH PCB 14 (23.2 ± 2.1), 4’-OH PCB 33 (12.1 ± 
7.2), and 4’-OH PCB 36 (9.7 ± 1.6). The rSULT2A3 that had been pretreated with either GSH or 
GSSG did not catalyze sulfation of any of the nine OHPCBs.   
Two of the OHPCBs that were substrates for rSULT1A1 under reducing conditions, 4’-
OH PCB 9 and 6’-OH PCB 35, were used to investigate the potential modulation of their 
sulfation by oxidation of rSULT1A1. As shown in Fig. 3A, sulfation of both OHPCBs catalyzed 
by GSSG-pretreated rSULT1A1 was only slightly increased when compared to that seen with 
GSH-pretreated enzyme.  Furthermore, the absence of substrate inhibition with 6’-OH PCB 35 
and the presence of substrate inhibition with 4’-OH PCB 9, were seen in both reduced and 
oxidized rSULT1A1-catalyzed reactions.  
The sulfation of four OHPCBs identified as substrates for oxidized rSULT1A1 was 




enzyme with 1 mM GSSG. Three of these compounds, namely 4’-OH PCB 6, 4-OH PCB 14 and 
4’-OH PCB 33, showed concentration-dependent sulfation (Fig. 3B), whereas 4’-OH PCB 36 
showed sulfation only at its limit of solubility, 50 μM. The sulfation of the three OHPCBs 
catalyzed by oxidized rSULT1A1 demonstrated a kinetic profile significantly different from that 
observed with most of the OHPCBs that were substrates for reduced rSULT1A1.  
 
Reversibility of oxidized rSULT1A1 in its ability to catalyze sulfation of 4’-OH PCB 6  
As shown in Table 2, the sulfation of 2-naphthol catalyzed by rSULT1A1 was slightly 
enhanced by pretreatment of the enzyme with 1 mM GSSG compared to that with 1 mM GSH 
(p<0.05). This effect was similar to that observed for the rates of sulfation of 4’-OH PCB 9 and 
6’-OH PCB 35 catalyzed by oxidized versus reduced rSULT1A1. Upon reducing the oxidized 
rSULT1A1 by subsequent treatment with 5 mM DTT, the catalytic activity with 2-naphthol as 
substrate was reduced to the original level as catalyzed by the enzyme pretreated with only DTT. 
For 4’-OH PCB 6, pretreatment of rSULT1A1 with 5 mM DTT or 1mM GSSG led to a more 
significant difference in its catalytic activity.   Under reducing conditions, 4’-OH PCB 6 was not 
a substrate for rSULT1A1, but after pretreatment of the enzyme with 1 mM GSSG, the rate of 
sulfation was 37.3 ± 4.0 nmoles of product/mg/min.  After reduction of the oxidized enzyme with 
5 mM DTT, it no longer catalyzed the sulfation of 4’-OH PCB 6. Thus, the effects of altering the 
thiol:disulfide environment of rSULT1A1 were fully reversible for 4’-OH PCB 6.   






Metabolic hydroxylation of PCBs to OHPCBs in humans and other mammals is catalyzed by 
various isoforms of CYP, and often represents an initial step in metabolism. Analyses of PCB 
metabolites in human populations have shown that OHPCBs are persistent in the blood, and 
hydroxylation has primarily occurred at the para-, and, with a lower frequency, at the meta- 
positions (Bergman et al., 1994; Sandau et al., 2000).  Studies on rats exposed to PCBs have resulted 
in similar findings;  i.e., 4(4’)-hydroxylated and 3(3’)-hydroxylated PCBs were the main metabolites 
(Chen et al., 1976; Schnellmann et al., 1984; Haraguchi et al., 2004).   It is particularly interesting 
that the concentrations of these OHPCB metabolites in blood may, in some cases, be higher than the 
parent PCBs, with additional selective concentration of OHPCBs in liver and other tissues (Bergman 
et al., 1994).   For example, one of 13 OHPCBs detected in rat plasma following a dose of Aroclor 
1254 was 4-OH-2,3,5,3’,4’-pentachlorobiphenyl, and this OHPCB was observed at concentrations of 
0.7-1.8 ng/mg lipid in the liver at various time points (Bergman et al., 1994).  Our calculations 
suggest that this is approximately equivalent to a concentration range of 0.1 – 0.3 μM.  Although 
caution is necessary in comparisons between concentrations of OHPCBs calculated based on tissue 
lipid content and concentrations utilized with the purified enzyme, a reasonable conclusion is that 
the tissue concentrations likely to be seen for the OHPCBs examined in our current study would be 
unlikely to have significant effects on the catalytic activity of rSULT2A3. Thus, our results indicate 
that the major family 2 SULT in rat liver differs significantly from the major family 2 SULT in 
human liver, hSULT2A1, in its interactions with OHPCBs.     For example, our recent studies 
indicate that 4-OH PCB 34 and 4’-OH PCB 68 are good substrates for hSULT2A1, and 4’-OH PCB 




In contrast to rSULT2A3, the major hepatic family 1 SULT in the rat, rSULT1A1, had 
significant interactions with OHPCBs.  For those OHPCBs that were substrates for rSULT1A1, the 
rate of product formation would depend directly on the concentration of the OHPCB, since they 
would likely be present at non-saturating concentrations.  Some inhibitory OHPCBs, particularly 
those with IC50 values in the sub-micromolar range, may be candidates for examination of in vivo 
inhibition of rSULT1A1.   
These results with rSULT1A1 can be compared with a previous report on human SULT1A1 
(Wang et al., 2006), where 18 OHPCBs were found to inhibit the sulfation of 4-nitrophenol 
catalyzed by recombinant hSULT1A1 and by human liver cytosol, and at least three of these also 
served as substrates.  Several OHPCBs used in that study were also included in our experiments, and 
there are similarities in the interactions of these OHPCBs with human and rat SULT1A1.  However, 
there are also some notable differences.  Unlike rSULT1A1 which was most potently inhibited by 
OHPCBs bearing the 3,5-dichloro-4-hydroxy substitution pattern (e.g., 4-OH PCB 14, 4-OH PCB 
34, and 4-OH PCB 36), OHPCBs with a 3,5-dichloro-4-hydroxy substitution pattern showed slightly 
weaker inhibition of hSULT1A1 than 3-chloro-4-hydroxy substituted PCBs (Wang et al., 2005).  In 
this regard, the rSULT1A1 is more similar to hSULT1E1 (human estrogen sulfotransferase), where 
the 3,5-dichloro-4-hydroxy substitution pattern in OHPCBs provided the most potent inhibition of 
hSULT1E1 (Kester et al., 2000).      
Taken together, the above findings with OHPCBs indicate that the major hepatic family 2 
SULTs in the rat and human (rSULT2A3 and hSULT2A1, respectively) are distinctly different in 
their interactions with OHPCBs, while the interactions of OHPCBs with rSULT1A1 have more 
similarities to the human family 1 SULTs than differences.  It should be noted that this does not 




possibility for other rat SULT2 isoforms to interact with OHPCBs cannot be excluded in the present 
study.   
The concentrations of OHPCBs present in blood and tissues are important determinants of their 
interactions with SULTs.  It is becoming increasingly apparent that concentrations of OHPCBs vary 
significantly with species and tissue.  Moreover, the roles of protein-binding of OHPCBs are 
receiving increasing attention as factors influencing these in vivo concentrations.    For example, 
recent studies on placental transfer of PCBs and OHPCBs in humans (Park, et al., 2008)  show that 
OHPCBs are more efficiently transferred than the parent PCBs.  This increased placental transfer to 
the fetus was proposed to be due to higher protein-binding of OHPCBs as opposed to the greater 
lipid distribution of the parent PCBs (Park, et al., 2008).  Further elaboration of differences in the 
transport and tissue concentrations of OHPCBs will undoubtedly facilitate analysis of potential in 
vivo interactions with SULTs.   
The kinetic characteristics of various OHPCBs as substrates for rSULT1A1 under standard assay 
(reduced) conditions demonstrated significant variations, with most showing substrate inhibition. 
The kinetic data for OHPCBs with substrate inhibition, however, were not described well by a 
simple Michaelis-Menten model.  4-Nitrophenol, a prototype substrate for rSULT1A1 that has been 
extensively studied, displays pronounced substrate inhibition in reactions catalyzed by reduced 
rSULT1A1, and this has been classified as a form of uncompetitive substrate inhibition (Marshall et 
al., 2000).  The underlying mechanism for this kinetic behavior is due to the formation of a dead end 
ternary complex: E-PAP-ROH (where E is the rSULT1A1, PAP is the reaction product derived from 
PAPS, and ROH is a phenolic substrate) (Marshall et al., 2000).  The binary complex of PAP bound 




substrates (e.g., 4-nitrophenol, OHPCBs, and others) to E-PAP may have differential effects on the 
stability of the inhibitory ternary complex (Marshall et al., 2000; Duffel et al., 2001).  
Compared to reduced rSULT1A1, oxidized rSULT1A1 exhibits profoundly altered 
kinetic interactions with its substrates. As exemplified with 4-nitrophenol and 2-naphthol, changes in 
pH optima (from 5.2 to 6.3 and 5.4 to 7.2, respectively), and disappearance of substrate inhibition 
have been observed upon oxidation of  rSULT1A1 with GSSG (Marshall et al., 1997; Marshall et al., 
1998; Marshall et al., 2000).  Additional changes in substrate specificity were seen upon oxidation of 
the enzyme with GSSG (Marshall et al., 2000).  Upon treatment of rSULT1A1 with GSSG in the 
present study, we observed the conversion of four of the nine inhibitory OHPCBs to substrates. The 
underlying structural modification responsible for the altered kinetic behavior upon treatment of 
rSULT1A1 with GSSG for short time periods has been shown to be the formation of a glutathione-
protein mixed disulfide at Cys66 followed by the formation of an intramolecular disulfide between 
Cys66 and Cys232 (Marshall et al., 1997).   As rSULT1A1 is oxidized further, e.g., treatment with 1 
mM GSSG at 25 °C for more than 1 h, additional cysteines form disulfide bonds and the specific 
activity of the enzyme is decreased;  after treatment for 12-24 h, all five cysteines are oxidized, and 
the enzyme is completely inactivated (Marshall et al., 1997; Marshall et al., 2000).  Homology 
modeling studies indicate that oxidation of Cys66 and Cys232 affects the conformation of the 
protein in the vicinity of the PAPS/PAP binding site, and therefore changes the dissociation of the E-
PAP-ROH dead-end complex (Duffel et al., 2001).  Thus, under oxidative conditions, the ternary 
complex E-PAP-ROH may undergo nucleotide exchange with PAPS and the catalytic cycle can 
proceed (Marshall et al., 2000). As noted in the previous studies on the mechanism of rSULT1A1 
under reduced and oxidized conditions, the changes due to initial disulfide formation are reversible 




dependent changes in the kinetic behavior of rSULT1A1 with 4’-OH PCB 6 were reversible by 
reduction with DTT (Table 2).   
As described in the original studies on the effect of oxidation on mechanism of the 
enzyme (Marshall et al., 1997; Marshall et al., 2000),  these effects of partial oxidation of cysteines 
in rSULT1A1 suggest an important regulatory mechanism whereby the specificity and kinetics of 
the enzyme can be altered by oxidative stress.  This is particularly intriguing in the case of the 
OHPCBs examined in the current study, since, for some OHPCBs, cellular oxidative stress may 
determine whether the molecule inhibits rSULT1A1 or is sulfated in a reaction catalyzed by the 
enzyme.  In addition to oxidative stress created by disease states or exposure to other xenobiotics, 
recent work on the potential role of quinone metabolites of PCBs and their involvement in creation 
of oxidative stress within cells (Amaro et al., 1996; Srinivasan et al., 2002) suggests that, by 
inducing oxidative stress, some OHPCBs may influence sulfation of other OHPCBs or interfere with 
other sulfation reactions.  Finally, the recent report of disulfide-mediated regulation of hSULT1E1 
(Maiti et al., 2007) and the presence of cysteine residues homologous to Cys66 in other SULTs 
suggest that the substrate-dependent nature of the effects seen with the OHPCBs in our current 
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    Fig. 1. OHPCBs were either substrates or inhibitors of rSULT1A1. (A) Six OHPCBs used in 
the present study were substrates for rSULT1A1. Data are the means ± standard errors 
of triplicate (4’-OH PCB 12 and 4’-OH PCB 35) or duplicate (4’-OH PCB 3, 4-OH PCB 
8, 4’-OH PCB 9, and 6’-OH PCB 35) determinations.  (B) Eight OHPCBs were 
inhibitors of rSULT1A1 with full inhibition of sulfation of 2-naphthol. Duplicate assays 
were utilized at each OHPCB concentration to determine IC50 values; the mean values 
for each concentration of OHPCB are shown. 
 
    Fig. 2. Structure-activity relationships for OHPCB-inhibition of rSULT1A1.  Panels A-C show 
relationships between IC50 values and the 3,5-dichloro-4-hydroxy substitution pattern.  
Panel D illustrates the importance of chlorine atoms in the 2 and 3 positions of the 
aromatic ring of a PCB bearing a 4-OH group.  Panel E shows the effects of a chlorine 
atom in the 2’ or 3’ position of the non-phenolic ring of a chloro-4-OH PCB.  
 
    Fig. 3. Sulfation of OHPCBs catalyzed by oxidized and reduced rSULT1A1. (A) rSULT1A1 
that had been either oxidized by pretreatment with 1 mM GSSG (solid lines; closed 
symbols) or reduced by pretreatment with 1 mM GSH (dashed lines; open symbols) 
catalyzed the sulfation of 6’-OH PCB 35 (● or ○) and 4’-OH PCB 9 (■ or □).  (B) 
rSULT1A1 pretreated with 1 mM GSSG catalyzed the sulfation of 4’-OH PCB 33 (Δ), 
4’-OH PCB 6 (◊), and 4-OH PCB 14 (▼).  Data are the means ± standard errors of 





Table 1. Inhibition of rSULT1A1 and rSULT2A3 by hydroxylated PCBs.  
OH PCB Chem. structure Solubilitya 
(μM) 
IC50 (μM) 
Rat SULT1A1 Rat SULT2A3 
 






































































































































































































aSolubility of each OHPCB was detected according to the light scattering intensity in the same 
solution as in the reactions.  




cThis is an approximate value due to 50% inhibition at the limit of solubility.  
dLess than 50% inhibition was reached within the limit of solubility.  








Table 2. Reversibility of catalytic changes in rSULT1A1 following oxidative modification of the 
enzyme. 
 Pretreatment of rSULT1A1a 
 5 mM DTT 1 mM GSSG DTT after GSSGb 
2-Naphthol, 250 μM 38.3±4.7 50.2±2.1 c  37.4±1.5 
4’-OH PCB 6, 100 μM 0 37.3±4.0 0 
 
a5 mM DTT (dithiothreitol) and/or 1 mM GSSG (oxidized glutathione) were incubated with the 
enzyme at 25°C for 1 hr before use in an assay for sulfotransferase activity. Data are the means 
and standard deviations of three determinations. 
bOne aliquot of GSSG-treated enzyme was further treated with DTT at 25 °C for 1h.  
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